Kathy Boltz, PhD

Orally delivered fexaramine had favorable effects on metabolic profiles in mice and may be effective for weight loss in humans.

Robert W Lash, MD, of the Endocrine Society, finds this study interesting and useful, but not a stinging indictment of acarbose.

Gender-specific programs accounting for a woman’s menstrual cycle may help women quit smoking.

Young female athletes my experience endocrine disorders, including menstrual problems and difficulty with bone mass, due to intense training.

N-terminal B-type natriuretic peptide concentrations may be an indicator of cardiovascular disease risk in women.

A systems pharmacology model may predict hepatotoxicity associated with troglitazone.

Richard Quinton, MD, offers his take on these study findings and what they may mean for clinical practice.

Low levels of dehydroepiandrosterone (DHEA) and its sulfate may predict increased risk for coronary heart disease in men.